Why Starling Oncology, Inc. (STLN) stock fell 10.7% on Thursday, November 12, 2026
Starling Oncology, Inc. (STLN) closed at $3.75, down 10.71% on Thursday, November 12, 2026, on volume of 6,546,098 shares (3.5× its 3-month average); market value about $400.0M, according to Nexqual market data (nexqual.com/moves/2026-11-12/STLN).
What happened: primary sources
Events Nexqual found for STLN on Thursday, November 12, 2026 or the trading day before (November 11, 2026), each linked to its primary source:
- Nov 12, 2026: SEC 8-K: Regulation FD disclosure source
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on STLN
STLN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 12, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:48 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:48 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt